GE HealthCare Announces Q2 2026 Preliminary Results; CFO Resigns

What Happened GE HealthCare filed an 8-K on July 23, 2026 announcing preliminary, unaudited revenue and earnings-per-share results for Q2 2026 via a press release (furnished as Exhibit 99). The same filing reports that CFO Jay Saccaro notified the company he will resign to take a role outside the medical technology industry; his last day will be August 14, 2026. George A. Newcomb, Controller and Chief Accounting Officer, was named interim Chief Financial Officer effective August 14, 2026 and will continue to serve in his current roles while the company searches for a permanent successor.

Key Details

• Filing date: July 23, 2026; press release on preliminary Q2 2026 revenue and EPS provided as Exhibit 99.
• CFO transition: Jay Saccaro will resign; last day August 14, 2026.
• Interim CFO: George Newcomb (age 59) appointed interim CFO effective August 14, 2026; he will remain Controller & Chief Accounting Officer.
• Compensation/relationships: No changes to Mr. Newcomb’s compensation and no reportable related-party transactions under Item 404(a).

Why It Matters Preliminary quarterly revenue and EPS announcements can move the stock and set expectations ahead of full quarterly filings; investors should review the Exhibit 99 press release for the specific numbers and watch for the company’s formal earnings release and filings. The CFO departure is material for financial leadership, but GE HealthCare appointed an experienced internal finance executive as interim CFO, which supports continuity in financial reporting while the company conducts a search for a permanent successor.